AI is about to change healthcare. These 43 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Cactus, you need to believe its pressure control and spoolable pipe businesses can convert industry activity into durable cash flows while managing cost and integration risks. The strong Q2 2026 revenue and net income help, but management’s guide for slightly lower Q3 revenue keeps the near term picture more restrained. That softer outlook does not appear to change the key risk right now, which is margin pressure from higher input costs and competitive pricing.
The 7% increase in the quarterly dividend to US$0.15 per Class A share is the most relevant announcement here, because it sits alongside softer Q3 guidance and a share price that has already run hard. For investors focused on catalysts, a higher dividend funded by current earnings can support the case for Cactus as a cash generative story, but it also raises the bar for sustaining margins if tariffs, steel costs or pricing headwinds intensify.
Yet behind the higher dividend and solid quarter, there is a risk investors should be aware of if margins come under pressure and...
Read the full narrative on Cactus (it's free!)
Cactus’ narrative projects $2.0 billion revenue and $401.1 million earnings by 2029.
Uncover how Cactus' forecasts yield a $63.56 fair value, a 6% downside to its current price.
Some of the lowest ranked analysts were assuming Cactus could lift margins enough to reach about US$359 million of earnings on roughly US$1.9 billion of revenue by 2029, which is a far more cautious view than the consensus and might be revisited now that we have this Q2 beat and softer Q3 guidance in hand.
Explore 3 other fair value estimates on Cactus - why the stock might be worth as much as 98% more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com